Have you ever had that annoying gritty feeling, like there’s sand trapped in your eyes? That’s just a glimpse of what people with dry eye disease (DED) experience. Beyond the feeling of grittiness, they often battle with symptoms like redness, burning and itchiness. Over time, these pesky issues can really throw a wrench in day-to-day […]
Navigating the Dry Eye Landscape: Advances, Options, and Access Read More »
Recent months have brought new waves of viral infections across the globe, particularly, monkeypox. Scientists first identified monkeypox in Denmark in the late 1950s in a colony of laboratory monkeys from Singapore that were going to be used for polio research. The monkeypox virus is within the same genus as smallpox—and the vaccine that was
The Latest Developments in Drug Approvals Each quarter, the RemedyOne Clinical team curates a drug pipeline report for our clients that shares insight into specialty and traditional drugs in development that are expected to launch within the next twelve months, with a focus on medications currently in Phase III studies. The report is a helpful
Q3 2021 Drug Pipeline Recap Read More »
The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and vaccines, altering our history, and creating an environment focused on both innovation and speed. Healthcare workers and scientists led the way in creating new treatments and prevention protocols in response to the COVID-19 pandemic. However, despite all the advances,
COVID-19 Treatment Update Read More »
There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care of a patient. As people age, multiple prescriptions are often prescribed to treat patients that have multiple conditions. However, if treatment regimens and medical history are not carefully reviewed by healthcare professionals and payors, a
The Implications of Polypharmacy on the Payor and Patient Read More »
Download our 2021 Q3 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in development that are expected to launch within the next twelve months, with a focus on medications currently in Phase III studies. The report is a helpful tool for your team to keep updated on the latest
2021 Q3 RemedyOne Quarterly Pipeline Report Read More »
Download our 2021 Q2 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in development that are expected to launch within the next twelve months, with a focus on medications currently in Phase III studies. The report is a helpful tool for your team to keep updated on the latest
2021 Q2 RemedyOne Quarterly Pipeline Report Read More »
